Funder: National Institutes of Health (NIH)
Due Dates: November 14, 2025 (forecasted)
Funding Amounts: Estimated total program funding: $73,000,000 | ~50 awards expected | UG1 Cooperative Agreement, multi-year support
Summary: Supports consortia of academic medical centers and community hospitals to enhance the diversity and generalizability of cancer clinical trial accrual and research in community oncology settings.
Key Information: Clinical trials are not allowed under this NOFO; participation in cancer care delivery studies is optional but encouraged.